nach oben

Erschienen in:

29.09.2023 | Original Article

Comparing the effect of peri-operative antibiotic prophylaxis only with continuous low-dose antibiotic treatment on the incidence of urinary tract infection and stent related-symptoms in patients undergoing Double-J (DJ) stent insertion following transurethral lithotripsy (TUL)

verfasst von: Reza Shahrokhi Damavand, Samaneh Esmaeili, Bahador Heidari Bateni, Ardalan Akhavan Tavakoli, Ehsan Kazemnezhad

Erschienen in: World Journal of Urology | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

There are some controversial data about the peri operative use of antibiotics after double-J (DJ) insertion. This study aimed to compare the rates of urinary tract infections (UTI) and stent-related symptoms (SRSs) in patients who received only perioperative antibiotic prophylaxis and those given continuous low-dose antibiotic therapy for the entire stent-indwelling time following transurethral lithotripsy (TUL).

Methods

In this randomized clinical trial 178 patients received intravenous antibiotic prophylaxis (ciprofloxacin 400 mg) before the TUL and then randomly divided into two groups to either receive no antibiotic treatment after procedure (group A, 90 patients) or to additionally receive a continuous low-dose antibiotic treatment with one ciprofloxacin 500 mg every 12 h for 3 days and then ciprofloxacin 250 mg once daily for the entire stent-indwelling time (group B, 88 patients). The rates of UTIs, SRSs and incidence of drug side-effects were evaluated in groups.

Results

A total of 7 patients had positive urine culture [group A: 4 (4.4%) vs. group B: 3 (3.4%); P = 0.722]. Only 1 patient in group B had febrile UTI in the mean duration of indwelling stent in situ. The rate of SRSs was 92.2% and 89.8% in Group A and B, respectively, with no significant difference (P = 0.609). A total of 4 patients in Group B complained of gastrointestinal side effects of ciprofloxacin.

Conclusion

Continuous low-dose antibiotic treatment has no role in reducing the incidence of UTIs and SRSs during the indwelling time of ureteral stents compared with the peri-operative antibiotic prophylaxis only.

Klis R, Korczak-Kozakiewicz E, Denys A, SosnowskiM Rozanski W (2009) Relationship between urinary tract infection and self-retaining Double-J catheter colonization. J Endourol. 23:1015–9CrossRefPubMed

Ando T, Kazama A (2021) Double J stent migration as renal penetration. Urol Case Rep 22(39):101759CrossRef

Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ (2003) Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 169(3):1065–1069CrossRefPubMed

Ando E, Monden K, Mitsuhata R, Kariyama R, Kumon H (2004) Biofilm formation among methicillin resistant Staphylococcus aureus isolates from patients with urinary tract infection. Acta Med Okayama 58:207–214PubMed

Reid G, Sobel JD (1987) Bacterial adherence in the pathogenesis of urinary tract infection: a review. Rev Infect Dis 9:470–487CrossRefPubMed

Ramaswamy K, Shah O (2012) Antibiotic prophylaxis after uncomplicated ureteroscopic stone treatment: is there a difference? J Endourol 26(2):122–125CrossRefPubMed

Akay AF, Aflay U, Gedik A, Sahin H, Bircan MK (2007) Risk factors for lower urinary tract infection and bacterial stent colonization in patients with a double J ureteral stent. Int Urol Nephrol 39:95–98CrossRefPubMed

Moltzahn F, Haeni K, Birkhäuser FD, Roth B, Thalmann GN, Zehnder P (2013) Peri-interventional antibiotic prophylaxis only vs continuous low-dose antibiotic treatment in patients with JJ stents: a prospective randomised trial analysing the effect on urinary tract infections and stent-related symptoms. BJU Int 111(2):289–295CrossRefPubMed

Paick SH, Park HK, Oh SJ, Kim HH (2003) Characteristics of bacterial colonization and urinary tract infection after indwelling of double J ureteral stent. Urology 62:214–217CrossRefPubMed

10.

Walter Stamm E (2005) Urinary tract infection. In: Kasper D, Braunwald E, Fauci A, Hauser S, Longo D, Jameson JL (eds) Harrison’s priciples of internal medicine, 16th edn. McGraw-Hill, New York

11.

Saderi H, Owlia P, Jalali Nadoushan MR, Zaeri F, Zandieh E (2006) A 3-Year study of demographic characteristics of patients with urinary tract infection, microbial etiology, and susceptibility of isolated bacteria to antibiotics in Shaheed Mostafa Khomeini Hospital. Iran J Pathol 1(3):99–104

12.

Linhares I, Raposo T, Rodrigues A, Almeida A (2013) Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009). BMC Infect Dis 13:19CrossRefPubMedPubMedCentral

13.

Ghafourian S, Sekawi Z, Neela V, Khosravi A, Rahbar M, Sadeghifard N (2012) Incidence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection. Sao Paulo Med J 130(1):37–43CrossRefPubMed

14.

Guggenbichler JP, Assadian O, Boeswald M, Kramer A (2011) Incidence and clinical implication of nosocomial infections associated with implantable biomaterials—catheters, ventilator-associated pneumonia, urinary tract infections. GMS Krankenhhyg Interdiszip. 6(1):Doc18PubMedPubMedCentral

15.

De Francesco MA, Ravizzola G, Peroni L, Negrini R, Manca N (2007) Urinary tract infections in Brescia, Italy: etiology of uropathogens and antimicrobial resistance of common uropathogens. Med Sci Monit 13(6):BR136-144PubMed

16.

Urologic procedures and antimicrobial prophylaxis. Available at https://www.auanet.org/guidelines/urologicproceduresandantimicrobial-prophylaxis-(2019). Accessed 6 Apr 2023

17.

Madhavan K, Rustagi S, Jena R, Singh UP, Ansari MS, Srivastava A et al (2021) A prospective randomized study to define the role of low dose continuous prophylactic antibiotics and anti-adherence agents in altering the microbial colonization related to indwelling double-J stents. Asian J Urol 8(3):269–274CrossRefPubMed

18.

Société de Pathologie Infectieuse de Langue Française (SPILF), Association Française d’Urologie (AFU), Société Française d’Hygiène Hospitalière (SF2H). Révision des recommandations de bonne pratique pour la prise en charge et la prévention des Infections Urinaires Associées aux Soins (IUAS) de l’adulte 2015.

19.

Antibioprophylaxie en chirurgie et médecine interventionnelle (patients adultes)—La SFAR. Société Fr D’Anesthésie Réanimation 2018.

20.

Souhail B, Charlot P, Deroudilhe G, Coblentz Y, Pierquet G, Gimel P et al (2020) Urinary tract infection and antibiotic use around ureteral stent insertion for urolithiasis. Eur J Clin Microbiol Infect Dis 39(11):2077–2083CrossRefPubMed

21.

Grabe M (2004) Controversies in antibiotic prophylaxis in urology. Int J Antimicrob Agents 23(Suppl. 1):S17-23CrossRefPubMed

22.

Geraghty RM, Pietropaolo A, Villa L, Fitzpatrick J, Shaw M, Veeratterapillay R et al (2022) Post-ureteroscopy infections are linked to pre-operative stent dwell time over two months: outcomes of three european endourology centres. J Clin Med 11(2):310CrossRefPubMedPubMedCentral

23.

Hanna B, Zhuo K, Chalasani V, Vass J, Rasiah K, Wines M et al (2021) Association between ureteric stent dwell time and urinary tract infection. ANZ J Surg 91(1–2):187–191CrossRefPubMed

24.

Akinci A, Kubilay E, Solak VT, Karaburun MC, Baklaci CU, Aydoğ E et al (2021) Effect of continuous antibiotic prophylaxis in children with postoperative JJ stents: a prospective randomized study. J Pediatr Urol 17(1):89–94CrossRefPubMed

25.

Kehinde EO, Rotimi VO, Al-Hunayan A, Abdul-Halim H, Boland F, Al-Awadi KA (2004) Bacteriology of urinary tract infection associated with indwelling J ureteral stents. J Endourol 18:891–896CrossRefPubMed

26.

Joshi HB, Okeke A, Newns N, Keeley FX Jr, Timoney AG (2002) Characterization of urinary symptoms in patients with ureteral stents. Urology 59(4):511–516CrossRefPubMed

27.

Betschart P, Zumstein V, Piller A, Schmid HP, Abt D (2017) Prevention and treatment of symptoms associated with indwelling ureteral stents: a systematic review. Int J Urol 24(4):250–259CrossRefPubMed

28.

Pecoraro A, Peretti D, Tian Z, Aimar R, Niculescu G, Alleva G et al (2023) Treatment of ureteral stent-related symptoms. Urol Int 107(3):288–303CrossRefPubMed

29.

Mendez-Probst CE, Goneau LW, MacDonald KW, Nott L, Seney S, Elwood CN et al (2012) The use of triclosan eluting stents effectively reduces ureteral stent symptoms: a prospective randomized trial. BJU Int 110(5):749–754CrossRefPubMed

Titel: Comparing the effect of peri-operative antibiotic prophylaxis only with continuous low-dose antibiotic treatment on the incidence of urinary tract infection and stent related-symptoms in patients undergoing Double-J (DJ) stent insertion following transurethral lithotripsy (TUL)
verfasst von: Reza Shahrokhi Damavand
Samaneh Esmaeili
Bahador Heidari Bateni
Ardalan Akhavan Tavakoli
Ehsan Kazemnezhad
Publikationsdatum: 29.09.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 11/2023
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-023-04585-8

Neu im Fachgebiet Urologie

Schützt auch die medikamentöse Gewichtsreduktion vor Krebs?

03.06.2024 ASCO 2024 Kongressbericht

Offenbar muss es nicht immer die bariatrische Chirurgie sein, wenn es darum geht, durch deutlichen Gewichtsverlust auch das Krebsrisiko günstig zu beeinflussen. Eine große Kohortenanalyse zur Behandlung mit GLP-1-Agonisten wurde dazu auf der ASCO-Tagung vorgestellt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Comparing the effect of peri-operative antibiotic prophylaxis only with continuous low-dose antibiotic treatment on the incidence of urinary tract infection and stent related-symptoms in patients undergoing Double-J (DJ) stent insertion following transurethral lithotripsy (TUL)